Showing results (151-160 of 189) with videos related to

Sort By:
Pageof 19
Cancers|September 28, 2023
Systematic Review of the Survival Outcomes of Neoadjuvant Chemotherapy in Women with Malignant Ovarian Germ Cell TumorsHitomi Sakaguchi-Mukaida, Shinya Matsuzaki, Yutaka Ueda, et al.
Radiation Oncology (London, England)|August 25, 2015
Intensity-modulated radiation therapy versus three-dimensional conformal radiation therapy with concurrent nedaplatin-based chemotherapy after radical hysterectomy for uterine cervical cancer: comparison of outcomes, complications, and dose-volume histogram parametersFumiaki Isohashi, Seiji Mabuchi, Yasuo Yoshioka, et al.
Scientific Reports|January 27, 2021
Prognostic significance of bone marrow FDG uptake in patients with gynecological cancerKotaro Shimura, Seiji Mabuchi, Naoko Komura, et al.
Oncoimmunology|November 20, 2019
The role of myeloid-derived suppressor cells in endometrial cancer displaying systemic inflammatory response: clinical and preclinical investigationsEriko Yokoi, Seiji Mabuchi, Naoko Komura, et al.
Cancer Immunology, Immunotherapy : CII|June 21, 2020
The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancerNaoko Komura, Seiji Mabuchi, Kotaro Shimura, et al.
Investigational New Drugs|October 31, 2018
Lurbinectedin (PM01183), a selective inhibitor of active transcription, effectively eliminates both cancer cells and cancer stem cells in preclinical models of uterine cervical cancerEriko Yokoi, Seiji Mabuchi, Kotaro Shimura, et al.
Endocrinology|January 7, 2006
Inhibition of phosphatidylinositol 3-kinase increases efficacy of cisplatin in in vivo ovarian cancer modelsTsuyoshi Ohta, Masahide Ohmichi, Tadashi Hayasaka, et al.
Journal of Radiation Research|January 17, 2019
A 3-year follow-up study of radiotherapy using computed tomography-based image-guided brachytherapy for cervical cancerAtsushi Kawashima, Fumiaki Isohashi, Seiji Mabuchi, et al.
Investigational New Drugs|September 3, 2017
Phase II basket trial of perifosine monotherapy for recurrent gynecologic cancer with or without PIK3CA mutationsKosei Hasegawa, Masahiro Kagabu, Mika Mizuno, et al.
Endocrinology|June 6, 2009
Up-regulation of alpha5-integrin by E-cadherin loss in hypoxia and its key role in the migration of extravillous trophoblast cells during early implantationEmi Arimoto-Ishida, Masahiro Sakata, Kenjiro Sawada, et al.
Pageof 19